MicroRNA 586 (miR-586)

MicroRNA 586 (miR-586) is a small, non-coding RNA molecule (approximately 21–23 nucleotides in length) involved in post-transcriptional regulation of gene expression. It is classified as a microRNA and plays a regulatory role by binding to target messenger RNAs (mRNAs), leading to their degradation or repression of translation. miR-586 has been identified as an oncogene in several cancers, particularly breast cancer, where it promotes tumor cell proliferation, invasion, metastasis, and reduces patient survival rates. Mechanistically, miR-586 activates Wnt/β-catenin signaling by directly repressing Wnt pathway antagonists such as SFRP1 and DKK2/3. miR-586 participates in a feedback regulatory axis with the lncRNA LINC01189 and the transcription factor ZEB1, controlling cancer cell epithelial-mesenchymal transition and progression. It can serve as a biomarker for disease prognosis but poses challenges for therapeutic intervention due to its multidimensional effects as a gene regulator[1][3][4].

Other names

hsa-miR-586MIRN586MIR586hsa-mir-586

miR-586 functions by silencing specific mRNAs involved in Wnt/β-catenin signaling by directly binding to antagonists such as SFRP1 and DKK2/3, resulting in activation of Wnt/β-catenin pathway and promoting oncogenic processes\nGeneral microRNA mechanisms include mRNA cleavage, destabilization, and translational inhibition